# US 2021/0277435 A1 · Production of human milk oligosaccharides in microbial hosts with engineered import / export

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2021/0277435 A1
- Document ID: US20210277435A1
- Status: Published application
- Kind: A1
- Application number: 17/323,737
- Filed: 2021-05-18
- Published: 2021-09-09
- Earliest claimed: 2015-09-12
- Assignees: Jennewein Biotechnologie GmbH
- Applicants: Jennewein Biotechnologie GmbH
- Inventors: Stefan JENNEWEIN; Dirk WARTENBERG
- Web page: https://patentgrep.com/patent/US20210277435A1

## CPC

- C12P 19/18: produced by the action of a glycosyl transferase, e.g. alpha-, beta- or gamma-cyclodextrins
- C12N 9/1051: {Hexosyltransferases (2.4.1)}
- C12N 15/70: Vectors or expression systems specially adapted for E. coli
- C12Y 204/01146: Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,3-N-acetylglucosaminyltransferase (2.4.1.146)
- C12P: FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE {(brewing of beer C12C; producing vinegar C12J; producing specific peptides or proteins C07K; producing enzymes C12N9/00; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification C12N15/00; measuring or testing processes involving enzymes or microorganisms C12Q; measuring or testing processes involving nucleic acid amplification reactions C12Q1/6844; fermentation processes to form a food composition, A21 or A23; compounds in general, see the relevant compound class, e.g. C01, C07)}
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)
- C12Y: ENZYMES

## Abstract

The present invention relates to methods for the production of oligosaccharides in genetically modified bacterial host cells, as well as to the genetically modified host cells used in the methods. The genetically modified host cell comprises at least one recombinant glycosyltransferase, and at least one nucleic acid sequence coding for a protein enabling the export of the oligosaccharide.

## Claims

### Claim 1

A method for the production of lacto-N-triose II by a genetically modified microbial host cell, comprising
providing a genetically modified microbial host cell that comprises:
at least one recombinant β-1,3-N-acetylglucosaminyltransferase,
increased expression or activity of at least one sugar export protein capable of exporting the lacto-N-triose II;
cultivating the microbial host cell in a medium under conditions permissive for the production of the lacto-N-triose II, whereby the lacto-N-triose II is exported into the medium at an increased level compared to the unmodified microbial host cell, and
obtaining the lacto-N-triose II from the medium.

### Claim 2 (depends on 1)

The method of claim 1, wherein the β-1,3-N-acetylglucosaminyltransferase belongs to the class of lgtA of Neisseria meningitidis or PmnagT of Pasteurella multocida, or variants thereof.

### Claim 3 (depends on 1)

The method of claim 1, wherein the at least one sugar export protein is selected from the group consisting of YjhB from Escherichia coli, ProP from Mannheimia succiniciproducens, SetA from Cedecea neteri, and functional fragments thereof.

### Claim 4 (depends on 1)

The method of claim 1, wherein, in the genetically modified microbial host cell, the endogenous β-galactosidase gene and the glucosamine-6-phosphate deaminase gene are inactivated in the host cell, and wherein said genetically modified microbial host cell comprises a nucleic acid sequence coding for a functional lactose permease protein.

### Claim 5 (depends on 1)

The method of claim 1, wherein the genetically modified microbial host cell comprises an increased UDP-N-acetylglucosamine and UDP-galactose or GDP-fucose or CMP-N-acetylneuraminic acid production capability as compared to a genetically unmodified host cell, wherein optionally said increased UDP-N-acetylglucosamine and UDP-galactose production capability is by the overexpression of one or more genes encoding a protein selected from the group consisting of L-glutamine: D-fructose-6-phosphate aminotransferase, N-acetyl glucosamine-1-phosphate uridyltransferase/glucosamine-1-phosphate acetyl transferase, phosphoglucosamine mutase, UDP-galactose-4-epimerase, phosphoglucomutase, and glucose-1-phosphate uridylyltransferase.

### Claim 6 (depends on 4)

The method according to claim 4, wherein said genetically modified microbial host cell is cultivated in the presence of glucose, sucrose, glycerol or a combination thereof.

### Claim 7 (depends on 6)

The method according to claim 6, wherein the microbial host cell is cultured in the absence of N-acetylglucosamine and galactose.

### Claim 8

A genetically modified microbial host cell for the production of lacto-N-triose II, wherein the microbial host cell comprises:
at least one recombinant β-1,3-N-acetylglucosaminyltransferase, and
increased expression or activity of at least one sugar export protein capable of exporting the lacto-N-triose II.

### Claim 9 (depends on 8)

The genetically modified microbial host cell of claim 8, wherein the β-1,3-N-acetylglucosaminyltransferase belongs to the class of lgtA of Neisseria meningitidis or PmnagT of Pasteurella multocida, or variants thereof.

### Claim 10 (depends on 8)

The genetically modified microbial host cell of claim 8, wherein the at least one sugar export protein is selected from the group consisting of YjhB from Escherichia coli, ProP from Mannheimia succiniciproducens, SetA from Cedecea neteri, and functional fragments thereof.

### Claim 11 (depends on 8)

The genetically modified microbial host cell of claim 8, wherein, in the genetically modified microbial host cell, the endogenous β-galactosidase gene and the glucosamine-6-phosphate deaminase gene are inactivated in the host cell, and wherein said genetically modified microbial host cell comprises a nucleic acid sequence coding for a functional lactose permease protein.

### Claim 12 (depends on 8)

The genetically modified microbial host cell of claim 8, wherein the genetically modified microbial host cell comprises an increased UDP-N-acetylglucosamine and UDP-galactose or GDP-fucose or CMP-N-acetylneuraminic acid production capability as compared to a genetically unmodified host cell, wherein optionally said increased UDP-N-acetylglucosamine and UDP-galactose production capability is by the overexpression of one or more genes encoding a protein selected from the group consisting of L-glutamine: D-fructose-6-phosphate aminotransferase, N-acetyl glucosamine-1-phosphate uridyltransferase/glucosamine-1-phosphate acetyl transferase, phosphoglucosamine mutase, UDP-galactose-4-epimerase, phosphoglucomutase, and glucose-1-phosphate uridylyltransferase.
